{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:13:11Z","timestamp":1794694391678,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) comprises a group of highly malignant tumors of the pancreas. Metabolic reprogramming in tumors plays a pivotal role in promoting cancer progression. However, little is known about the metabolic alterations in tumors that drive cancer drug resistance in patients with PDAC. Here, we identified acyl-CoA thioesterase 8 (ACOT8) as a key player in driving PDAC gemcitabine (GEM) resistance. The expression of ACOT8 is significantly upregulated in GEM-resistant PDAC tissues and is closely associated with poor survival in patients with PDAC. Gain- and loss-of-function studies have shown that ACOT8 drives PDAC GEM resistance both in vitro and in vivo. Mechanistically, ACOT8 regulates cellular cholesterol ester (CE) levels, decreases the levels of phosphatidylethanolamines (PEs) that bind to polyunsaturated fatty acids and promote peroxisome activation. The knockdown of ACOT8 promotes ferroptosis and increases the chemosensitivity of tumors to GEM by inducing ferroptosis-associated pathway activation in PDAC cell lines. The combination of orlistat, an ACOT8 inhibitor, and GEM significantly inhibited tumor growth in PDAC organoid and mouse models. This study reveals the biological importance of ACOT8 and provides a potential combination therapy for treating patients with advanced GEM-resistant PDAC.<\/jats:p>","DOI":"10.1038\/s41401-025-01477-y","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:05:51Z","timestamp":1739336751000},"page":"1742-1756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"46","author":[{"given":"Bo-rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-feng","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-xiong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-sheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"1477_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1477_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321.","journal-title":"Cancer Res"},{"key":"1477_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1477_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1074\/jbc.M106458200","volume":"277","author":"MC Hunt","year":"2002","unstructured":"Hunt MC, Solaas K, Kase BF, Alexson SE. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J Biol Chem. 2002;277:1128\u201338.","journal-title":"J Biol Chem"},{"key":"1477_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yexcr.2004.02.029","volume":"297","author":"M Ishizuka","year":"2004","unstructured":"Ishizuka M, Toyama Y, Watanabe H, Fujiki Y, Takeuchi A, Yamasaki S, et al. Overexpression of human acyl-CoA thioesterase upregulates peroxisome biogenesis. Exp Cell Res. 2004;297:127\u201341.","journal-title":"Exp Cell Res"},{"key":"1477_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tem.2017.03.001","volume":"28","author":"V Tillander","year":"2017","unstructured":"Tillander V, Alexson SEH, Cohen DE. Deactivating fatty acids: acyl-CoA thioesterase-mediated control of lipid metabolism. Trends Endocrinol Metab. 2017;28:473\u201384.","journal-title":"Trends Endocrinol Metab"},{"key":"1477_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.plipres.2010.04.001","volume":"49","author":"B Kirkby","year":"2010","unstructured":"Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog lipid Res. 2010;49:366\u201377.","journal-title":"Prog lipid Res"},{"key":"1477_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.prp.2013.02.008","volume":"209","author":"WY Jung","year":"2013","unstructured":"Jung WY, Kim YH, Ryu YJ, Kim BH, Shin BK, Kim A, et al. Acyl-CoA thioesterase 8 is a specific protein related to nodal metastasis and prognosis of lung adenocarcinoma. Pathol Res Pract. 2013;209:276\u201383.","journal-title":"Pathol Res Pract"},{"key":"1477_CR9","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.3892\/or.2014.3155","volume":"31","author":"YH Hung","year":"2014","unstructured":"Hung YH, Chan YS, Chang YS, Lee KT, Hsu HP, Yen MC, et al. Fatty acid metabolic enzyme acyl-CoA thioesterase 8 promotes the development of hepatocellular carcinoma. Oncol Rep. 2014;31:2797\u2013803.","journal-title":"Oncol Rep"},{"key":"1477_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.594969","volume":"11","author":"CL Xu","year":"2020","unstructured":"Xu CL, Chen L, Li D, Chen FT, Sha ML, Shao Y. Acyl-CoA thioesterase 8 and 11 as novel biomarkers for clear cell renal cell carcinoma. Front Genet. 2020;11:594969.","journal-title":"Front Genet."},{"key":"1477_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02264-5","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao S, Li P, Wu W, Wang Q, Qian B, Li X, et al. Roles of ferroptosis in urologic malignancies. Cancer Cell Int. 2021;21:676.","journal-title":"Cancer Cell Int."},{"key":"1477_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376.","journal-title":"Trends Cell Biol."},{"key":"1477_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369\u201379.","journal-title":"Cell Death Differ"},{"key":"1477_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31:e1904197.","journal-title":"Adv Mater"},{"key":"1477_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"1477_CR17","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3390\/ijms222010944","volume":"22","author":"J Yang","year":"2021","unstructured":"Yang J, Xu J, Zhang B, Tan Z, Meng Q, Hua J, et al. Ferroptosis: at the crossroad of gemcitabine resistance and tumorigenesis in pancreatic cancer. Int J Mol Sci. 2021;22:10944.","journal-title":"Int J Mol Sci"},{"key":"1477_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"1477_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101807","volume":"38","author":"Z Ye","year":"2021","unstructured":"Ye Z, Zhuo Q, Hu Q, Xu X, Mengqi L, Zhang Z, et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biol. 2021;38:101807.","journal-title":"Redox Biol"},{"key":"1477_CR20","first-page":"657","volume":"58","author":"Study Group of Pancreatic Surgery in China Society of Surgery of Chinese Medical A, Pancreatic Disease Committee of China Research Hospital A","year":"2020","unstructured":"Study Group of Pancreatic Surgery in China Society of Surgery of Chinese Medical A, Pancreatic Disease Committee of China Research Hospital A. [The guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition)]. Zhonghua Wai Ke Za Zhi. 2020;58:657\u201367.","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J cancer (Oxf, Engl : 1990). 2009;45:228\u201347.","journal-title":"Eur J cancer (Oxf, Engl : 1990)"},{"key":"1477_CR22","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"1477_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-021-00294-7","volume":"16","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li S, Li F, Lv C, Yang QK. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma. Biol Direct. 2021;16:10.","journal-title":"Biol Direct"},{"key":"1477_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell L, Surumbayeva A, Peri S, Franco-Barraza J, Restifo D, Weitz N, et al. Cholesterol pathway inhibition induces TGF-beta signaling to promote basal differentiation in pancreatic cancer. Cancer Cell. 2020;38:567\u201383 e511.","journal-title":"Cancer Cell"},{"key":"1477_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-022-02261-0","volume":"41","author":"S Yu","year":"2022","unstructured":"Yu S, Wang L, Che D, Zhang M, Li M, Naito M, et al. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. J Exp Clin Cancer Res: CR. 2022;41:88.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"1477_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s13402-022-00694-5","volume":"45","author":"J Gu","year":"2022","unstructured":"Gu J, Zhu N, Li HF, Zhao TJ, Zhang CJ, Liao DF, et al. Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor. Cell Oncol (Dordr). 2022;45:709\u201328.","journal-title":"Cell Oncol (Dordr)"},{"key":"1477_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee JY, Oh M, Lee EW. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med. 2023;55:1620\u201331.","journal-title":"Exp Mol Med"},{"key":"1477_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1021\/acs.chemrestox.8b00269","volume":"32","author":"BJ You","year":"2019","unstructured":"You BJ, Chen LY, Hsu PH, Sung PH, Hung YC, Lee HZ. Orlistat displays antitumor activity and enhances the efficacy of paclitaxel in human hepatoma Hep3B cells. Chem Res Toxicol. 2019;32:255\u201364.","journal-title":"Chem Res Toxicol."},{"key":"1477_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s11684-020-0804-7","volume":"15","author":"W Zhou","year":"2021","unstructured":"Zhou W, Zhang J, Yan M, Wu J, Lian S, Sun K, et al. Orlistat induces ferroptosis-like cell death of lung cancer cells. Front Med. 2021;15:922\u201332.","journal-title":"Front Med"},{"key":"1477_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L, et al. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J Exp Clin cancer Res: CR. 2023;42:6.","journal-title":"J Exp Clin cancer Res: CR"},{"key":"1477_CR32","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1016\/S1470-2045(13)70172-4","volume":"14","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Werner J, Jager D, Debus J, Buchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14:e476\u2013e485.","journal-title":"Lancet Oncol"},{"key":"1477_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/1120009X.2022.2026125","volume":"34","author":"S Ay","year":"2022","unstructured":"Ay S, Atci MM, Arikan R, Dulgar O, Ozyukseler DT, Paksoy N, et al. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. J Chemother. 2022;34:465\u201371.","journal-title":"J Chemother"},{"key":"1477_CR34","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/cancers14102486","volume":"14","author":"T Koltai","year":"2022","unstructured":"Koltai T, Reshkin SJ, Carvalho TMA, Di Molfetta D, Greco MR, Alfarouk KO, Cardone RA, et al. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers (Basel). 2022;14:2486.","journal-title":"Cancers (Basel)"},{"key":"1477_CR35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"1477_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat. 2023;68. 100960.","journal-title":"Drug Resist Updat"},{"key":"1477_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.molcel.2006.10.024","volume":"24","author":"WA Stanley","year":"2006","unstructured":"Stanley WA, Filipp FV, Kursula P, Sch\u00fcller N, Erdmann R, Schliebs W, et al. Recognition of a functional peroxisome type 1 target by the dynamic import receptor pex5p. Mol Cell. 2006;24:653\u201363.","journal-title":"Mol Cell"},{"key":"1477_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220296120","volume":"120","author":"B Liu","year":"2023","unstructured":"Liu B, Shen H, He J, Jin B, Tian Y, Li W, et al. Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. Proc Natl Acad Sci USA. 2023;120:e2220296120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1477_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2021.09.009","volume":"37","author":"C Shang","year":"2022","unstructured":"Shang C, Li Y, He T, Liao Y, Du Q, Wang P, et al. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer. J Adv Res. 2022;37:169\u201384.","journal-title":"J Adv Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01477-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T06:33:05Z","timestamp":1747895585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01477-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01477-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}